Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 10-Q: Quarterly report
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed Form 10-Q (quarterly report) with the SEC on Oct 29, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More SUPN filings
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Oct 19, 2026
- 8-K
Filed Oct 15, 2026
- 425
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.